Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131504 · ClinicalTrials.gov registry record
Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 239
- Enrollment target
NCT04131504 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 239 participants.
The verdict
NCT04131504 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 239 participants
- Enrollment target
Study Summary
Crohn's disease and ulcerative colitis affect about 1.6 to 3 million people in the United States with many of those being young children and adolescents. Physicians need better ways to inform decisions on therapy selection and recognize ongoing intestinal injury while on treatment. The main reason for this research study is to see if a blood test or stool test, which measures specific proteins, taken just before starting a new treatment for Crohn's disease can predict a patient's ability to achieve complete intestinal healing. The investigators also want to see if the intensity of gut inflammation can be detected by measuring a separate set of proteins in the blood.
Interventions
- DRUG Adalimumab
- DRUG Infliximab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2019-10-16 |
| Est. Completion | 2023-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04131504
The ClinicalTrials.gov registry entry for NCT04131504 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adalimumab is the first listed.
NCT04131504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04131504 about?
NCT04131504 is a clinical study titled "Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)". Crohn's disease and ulcerative colitis affect about 1.6 to 3 million people in the United States with many of those being young children and adolescents. Physicians need better ways to inform decisions on therapy selection and recognize ongoing intestinal injury while on treatment. The main reason ...
What is the current status of trial NCT04131504?
This trial is currently completed. The enrollment target is 239 participants. The study started on 2019-10-16. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT04131504?
The interventions under investigation include: Adalimumab (DRUG), Infliximab (DRUG).
Who is sponsoring clinical trial NCT04131504?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.